168 related articles for article (PubMed ID: 38497192)
41. Intranasal fentanyl for the management of acute pain in children.
Murphy A; O'Sullivan R; Wakai A; Grant TS; Barrett MJ; Cronin J; McCoy SC; Hom J; Kandamany N
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD009942. PubMed ID: 25300594
[TBL] [Abstract][Full Text] [Related]
42. Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.
Simpson KN; Fossler MJ; Wase L; Demitrack MA; Wandstrat TL
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):671-681. PubMed ID: 35129031
[TBL] [Abstract][Full Text] [Related]
43. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
44. Less postoperative nausea and vomiting after propofol + remifentanil versus propofol + fentanyl anaesthesia during plastic surgery.
Rama-Maceiras P; Ferreira TA; Molíns N; Sanduende Y; Bautista AP; Rey T
Acta Anaesthesiol Scand; 2005 Mar; 49(3):305-11. PubMed ID: 15752393
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the Effects of Sufentanil and Fentanyl in Intravenous Patient-Controlled Analgesia after Pediatric Moyamoya Surgery: A Retrospective Study.
Lim L; Jang YE; Kim EH; Lee JH; Kim JT; Kim HS
Pediatr Neurosurg; 2020; 55(1):36-41. PubMed ID: 31940654
[TBL] [Abstract][Full Text] [Related]
46. Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial.
Zeng X; Zhu J; Li J; Chen C; Sang L; Liu M; Song L; Liu H
J Pain Symptom Manage; 2024 Jan; 67(1):50-58. PubMed ID: 37742793
[TBL] [Abstract][Full Text] [Related]
47. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report.
Mantovani G; Curreli L; Macciò A; Massa E; Massa D; Mulas C; Succu G; Contu P
Anticancer Res; 1999; 19(4C):3495-502. PubMed ID: 10629642
[TBL] [Abstract][Full Text] [Related]
48. Fentanyl iontophoretic transdermal system for acute-pain management after orthopedic surgery: a comparative study with morphine intravenous patient-controlled analgesia.
Hartrick CT; Bourne MH; Gargiulo K; Damaraju CV; Vallow S; Hewitt DJ
Reg Anesth Pain Med; 2006; 31(6):546-54. PubMed ID: 17138198
[TBL] [Abstract][Full Text] [Related]
49. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.
Wiffen PJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD011056. PubMed ID: 24874470
[TBL] [Abstract][Full Text] [Related]
50. The effects of acupuncture point Pericardium 6 on hydromorphone-induced nausea and vomiting in healthy dogs.
Scallan EM; Simon BT
Vet Anaesth Analg; 2016 Sep; 43(5):495-501. PubMed ID: 26890432
[TBL] [Abstract][Full Text] [Related]
51. Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
Johnson RA
Vet Anaesth Analg; 2014 Jul; 41(4):406-10. PubMed ID: 24330310
[TBL] [Abstract][Full Text] [Related]
52. Satisfactory Analgesia with Minimal Emesis in Day Surgeries (SAME DayS): a protocol for a randomised controlled trial of morphine versus hydromorphone.
Shanthanna H; Paul J; Lovrics P; Devereaux PJ; Bhandari M; Thabane L
BMJ Open; 2018 Jun; 8(6):e022504. PubMed ID: 29934395
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and adverse effects of patient-controlled epidural or intravenous analgesia after major surgery.
Teng YH; Hu JS; Tsai SK; Liew C; Lui PW
Chang Gung Med J; 2004 Dec; 27(12):877-86. PubMed ID: 15754777
[TBL] [Abstract][Full Text] [Related]
54. Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery.
Yang Y; Wu J; Li H; Ye S; Xu X; Cheng L; Zhu L; Peng Z; Feng Z
BMC Anesthesiol; 2018 Apr; 18(1):37. PubMed ID: 29636011
[TBL] [Abstract][Full Text] [Related]
55. Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine.
Dahan A; van Dam CJ; Niesters M; van Velzen M; Fossler MJ; Demitrack MA; Olofsen E
Anesthesiology; 2020 Sep; 133(3):559-568. PubMed ID: 32788558
[TBL] [Abstract][Full Text] [Related]
56. Epidural morphine vs hydromorphone in post-caesarean section patients.
Halpern SH; Arellano R; Preston R; Carstoniu J; O'Leary G; Roger S; Sandler A
Can J Anaesth; 1996 Jun; 43(6):595-8. PubMed ID: 8773867
[TBL] [Abstract][Full Text] [Related]
57. Prevention of Opioid-Induced Nausea and Vomiting During Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg.
Zuniga JR; Papas AS; Daniels SE; Patrick K; Muse DD; Oreadi D; Giannakopoulos HE; Granquist EJ; Levin LM; Chou JC; Maibach H; Schachtel BP
Pain Med; 2019 Dec; 20(12):2528-2538. PubMed ID: 30657996
[TBL] [Abstract][Full Text] [Related]
58. Oliceridine: First Approval.
Markham A
Drugs; 2020 Nov; 80(16):1739-1744. PubMed ID: 33025536
[TBL] [Abstract][Full Text] [Related]
59. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
60. The Effect of Dexmedetomidine on Postoperative Opioid Consumption and Pain After Major Spine Surgery.
Naik BI; Nemergut EC; Kazemi A; Fernández L; Cederholm SK; McMurry TL; Durieux ME
Anesth Analg; 2016 May; 122(5):1646-53. PubMed ID: 27003917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
